Fulcrum Therapeutics
FULC
$3.01
Share price
-2.59%
Change (1 day)
-67.67%
Change (1 year)
Categories
Fulcrum Therapeutics (FULC) - Cash on Hand
Cash on Hand as of December 2024 : $0.24 Billion USD
According to Fulcrum Therapeutics's latest financial reports the company has $0.24 Billion USD in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Fulcrum Therapeutics - Cash on Hand chart (from 2018 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | $0.24 B | 2.03% |
| 2023-12-31 | $0.23 B | 16.41% |
| 2022-12-31 | $0.20 B | -6.99% |
| 2021-12-31 | $0.21 B | 93.21% |
| 2020-12-31 | $0.11 B | 16.75% |
| 2019-12-31 | $96.71 M | 32.85% |
| 2018-12-31 | $72.79 M | 17786.24% |
| 2017-12-31 | $0.4 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 | $0.25 B | 6.20% | 🇺🇸 USA |